[1]
Andriyanto, D.B. et al. 2026. Comparison of Rituximab and Its Biosimilar in Chemotherapy Regimens for Non-Hodgkin Lymphoma Patients at Persahabatan Hospital. JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X. 18, 2 (Jul. 2026), 198–207. DOI:https://doi.org/10.35617/jfionline.v18i2.488.